Cite
Findings from University of Verona Has Provided New Data on Relapsing-Remitting Multiple Sclerosis (Effect of Glatiramer Acetate On Cerebral Grey Matter Pathology In Patients With Relapsing-remitting Multiple Sclerosis)
MLA
“Findings from University of Verona Has Provided New Data on Relapsing-Remitting Multiple Sclerosis (Effect of Glatiramer Acetate On Cerebral Grey Matter Pathology In Patients With Relapsing-Remitting Multiple Sclerosis).” Obesity, Fitness & Wellness Week, May 2019, p. 1431. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.585200192&authtype=sso&custid=ns315887.
APA
Findings from University of Verona Has Provided New Data on Relapsing-Remitting Multiple Sclerosis (Effect of Glatiramer Acetate On Cerebral Grey Matter Pathology In Patients With Relapsing-remitting Multiple Sclerosis). (2019, May 18). Obesity, Fitness & Wellness Week, 1431.
Chicago
Obesity, Fitness & Wellness Week. 2019. “Findings from University of Verona Has Provided New Data on Relapsing-Remitting Multiple Sclerosis (Effect of Glatiramer Acetate On Cerebral Grey Matter Pathology In Patients With Relapsing-Remitting Multiple Sclerosis),” May 18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.585200192&authtype=sso&custid=ns315887.